Will the Minister of AYURVEDA, YOGA AND NATUROPATHY, UNANI, SIDDHA AND HOMOEOPATHY (AYUSH) be pleased to state:
(a) whether the Government is considering to review AYUSH policy, if so, the details thereof;
(b) the details of the relief measures to be taken by the Government for the industries associated with AYUSH; and
(c) the steps being taken by the Government to promote the use of AYUSH products in the country?
ANSWER
THE MINISTER OF STATE (IC) OF THE MINISTRY OF AYURVEDA,
YOGA & NATUROPATHY, UNANI, SIDDHA AND HOMOEOPATHY
(SHRI SHRIPAD YESSO NAIK)
(a): No. The inputs regarding AYUSH were provided to Ministry of Health & Family Welfare which was subsequently included in the National Health Policy (NHP), 2017 duly approved by the Cabinet.
(b): Ministry of AYUSH has written to Department of Revenue for consideration of reducing direct and indirect taxation on ASU&H medicines in the context of Union budget for 2019-20. Ministry of AYUSH provides incentives to drug manufacturers, entrepreneurs, AYUSH institutions for participation in national and international exhibitions, road shows, trade fairs etc. Ministry of AYUSH also supports market authorization/ registration of AYUSH products with USFDA/EMEA/UKMHRA and their internal regulatory agencies.
(c): Quality Control provisions are framed and amended time to time to promote the manufacturing of quality medicinal products. Ministry of AYUSH has published Essential Drug lists of Ayurveda, Siddha, Unani & Homeopathy to facilitate supply of medicines to hospitals and dispensaries in the states through Centrally Sponsored Scheme of National AYUSH Mission.
…………………….